| Proposed Ticker: | KNTX | 3080 Raymond Street | |
| Exchange: | NASDAQ-National Market | Santa Clara, California 95054 | |
| Industry: | Construction | (408) 727-7740 |
| All share information is proposed | ||||
| Type of Shares: | Common Shares | Filing Date: | 12/12/96 | |
| U.S. Shares Filed: | 3,700,000 | Filing Range: | $14.00 - $16.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $55,500,000 | |
| Primary Shares: | 3,050,000 | Expenses: | $750,000 | |
| Secondary Shares: | 650,000 | Shs Out After: | 12,581,919 | |
| Manager | Tier | Phone |
| Smith Barney Inc. | Lead Manager | (718) 921-8473 |
| BT Securities Corporation | Co-manager | (212) 250-5000 |
| Donaldson, Lufkin & Jenrette Securities Corp. | Co-manager | (212) 504-4525 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 9/30/96 | 9/30/96 | ||||
| Revenue: | $278.42 | Assets: | $98.98 | ||
| Net Income: | $8.73 | Liabilities: | $71.20 | ||
| EPS: | $0.87 | Equity: | $27.78 | ||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is the leading provider of sophisticated high-purity process piping systems for the semiconductor, pharmaceutical and biotechnology industries. The company offers its customers turnkey solutions by providing, as a complement to its specialty high-purity contracting business, comprehensive and technically advanced engineering and design services, quality assurance and control services, program management services, and manufacturing of specialty components. The company prides itself on its ability to secure repeat business with its customers on both new construction and retrofit projects. In fiscal 1996, 89% of revenues were derived from repeat customers. The company's semiconductor customers currently include AMD, DEC, Hyundai, Intel, LAM Research, LSI Logic, Lucent Technologies, Motorola, Rockwell, SGS Thomson Semiconductor and Texas Instruments. The company's pharmaceutical and biotechnology customers currently include Alcon, Bayer, Chiron, Genetech, Genetics Institute, IDEC, Merck, Ortho Diagnostics and Warner Lambert. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to fund domestic and international expansion, including operations, facilities and equipment, as well as potential acquisitions; repayment of debt; working capital and for general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.